TELA Logo

TELA Bio, Inc. (TELA) 

NASDAQ
Market Cap
$110.51M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
136 of 776
Rank in Industry
16 of 100

Largest Insider Buys in Sector

TELA Stock Price History Chart

TELA Stock Performance

About TELA Bio, Inc.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile …

Insider Activity of TELA Bio, Inc.

Over the last 12 months, insiders at TELA Bio, Inc. have bought $519,598 and sold $2.02M worth of TELA Bio, Inc. stock.

On average, over the past 5 years, insiders at TELA Bio, Inc. have bought $13.99M and sold $1.54M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Cuca Roberto (COO and CFO) — $569,811. KOBLISH ANTONY (Chief Executive Officer) — $249,974. Talmo Paul (Chief Technology Officer) — $50,000.

The last purchase of 88,888 shares for transaction amount of $199,998 was made by KOBLISH ANTONY (Chief Executive Officer) on 2024‑10‑24.

List of Insider Buy and Sell Transactions, TELA Bio, Inc.

2024-10-24PurchaseChief Executive Officer
88,888
0.325%
$2.25$199,9980.00%
2024-10-24PurchaseCOO and CFO
64,444
0.2356%
$2.25$144,9990.00%
2024-10-24PurchaseChief Technology Officer
22,222
0.0813%
$2.25$50,0000.00%
2024-10-24PurchaseChief Commercial Officer
6,666
0.0244%
$2.25$14,9990.00%
2024-07-02Sale10 percent owner
36,600
0.1299%
$4.54$166,1640.00%
2024-07-01Sale10 percent owner
13,700
0.0501%
$4.68$64,1160.00%
2024-06-28Sale10 percent owner
378,000
1.4002%
$4.74$1.79M0.00%
2023-12-05PurchaseChief Business Officer
2,600
0.011%
$5.65$14,688-0.37%
2023-11-14PurchaseChief Executive Officer
11,000
0.0454%
$4.54$49,976+16.70%
2023-11-14PurchaseCOO and CFO
10,000
0.0408%
$4.49$44,938+16.70%
2023-04-21Sale10 percent owner
27,700
0.1432%
$9.41$260,657-24.97%
2023-04-20Sale10 percent owner
28,300
0.1502%
$9.43$266,869-22.89%
2023-04-19Sale10 percent owner
136,000
0.7142%
$9.30$1.26M-22.43%
2022-11-03Purchasedirector
20,262
0.1236%
$7.81$158,285+26.43%
2022-10-11Purchasedirector
16,000
0.0971%
$8.00$128,000+22.84%
2022-08-17Purchase
500,000
2.8654%
$8.00$4M+19.45%
2022-08-16Purchase
15,000
0.0881%
$8.00$120,000+22.39%
2022-08-10Purchase
11,500
0.0684%
$8.52$98,006+16.37%
2022-08-01Purchase10 percent owner
4,979
0.0296%
$7.96$39,632+24.38%
2022-07-22Purchase
5,000
0.0299%
$8.02$40,105+24.06%

Insider Historical Profitability

<0.0001%
ORBIMED ADVISORS LLC10 percent owner
2407242
6.5568%
$3.0116+2.92%
KOBLISH ANTONYChief Executive Officer
458897
1.2499%
$3.0120
Cuca RobertoCOO and CFO
155388
0.4232%
$3.0170<0.0001%
Talmo PaulChief Technology Officer
91082
0.2481%
$3.0110
Firestone Gregory A.Chief Commercial Officer
57279
0.156%
$3.0120

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Essex Woodlands Management Inc$23.31M16.674.11M0%+$06.78
OrbiMed$16.08M11.52.84M0%+$00.12
First Light Asset Management$15.62M11.172.75M+7.8%+$1.13M1.32
Aigh Capital Management Llc$8.02M5.741.42M+2.71%+$211,547.704.59
Nantahala Capital Management Llc$6.22M4.451.1M0%+$00.29
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.